Sector Gamma As Buys Biomarin Pharmaceutical Inc, Cigna Corp, Vertex Pharmaceuticals Inc, Sells Merck Inc, Baxter International Inc, Pfizer Inc

• New Purchases: BMRN, CI, VRTX, BNTX, VIR,
• Added Positions: INCY, CVS, MDT, NVAX, BIO,
• Reduced Positions: MRK, PFE, XRAY, QGEN, BMY, BRKR, GILD, BIIB, BSX, LH, OGN, NUVA, ANTM, ELAN, CNC, IONS, PDCO, BDX, CAH, RIGL, UHS, SAGE,
• Sold Out: BAX,

For the details of SECTOR GAMMA AS's stock buys and sells, go to https://www.gurufocus.com/guru/sector+gamma+as/current-portfolio/portfolio

1. Merck & Co Inc (MRK) - 475,804 shares, 8.57% of the total portfolio. Shares reduced by 41.46%
2. Incyte Corp (INCY) - 378,852 shares, 6.54% of the total portfolio. Shares added by 25.14%
3. Cardinal Health Inc (CAH) - 496,680 shares, 6.01% of the total portfolio. Shares reduced by 5.14%
4. Bristol-Myers Squibb Co (BMY) - 348,591 shares, 5.11% of the total portfolio. Shares reduced by 21.67%
5. Gilead Sciences Inc (GILD) - 297,055 shares, 5.07% of the total portfolio. Shares reduced by 19.95%

Sector Gamma As initiated holding in Biomarin Pharmaceutical Inc. The purchase prices were between $71.72 and $91.47, with an estimated average price of $82.84. The stock is now traded at around $88.510000. The impact to a portfolio due to this purchase was 2.36%. The holding were 113,548 shares as of 2021-12-31.

Sector Gamma As initiated holding in Cigna Corp. The purchase prices were between $191.9 and $231.65, with an estimated average price of $212.85. The stock is now traded at around $231.770000. The impact to a portfolio due to this purchase was 2.24%. The holding were 41,500 shares as of 2021-12-31.

Sector Gamma As initiated holding in Vertex Pharmaceuticals Inc. The purchase prices were between $177.01 and $223.45, with an estimated average price of $194.99. The stock is now traded at around $240.940000. The impact to a portfolio due to this purchase was 2.02%. The holding were 39,069 shares as of 2021-12-31.

Sector Gamma As initiated holding in BioNTech SE. The purchase prices were between $216.64 and $362.52, with an estimated average price of $274.36. The stock is now traded at around $159.600000. The impact to a portfolio due to this purchase was 0.79%. The holding were 13,032 shares as of 2021-12-31.

Sector Gamma As initiated holding in Vir Biotechnology Inc. The purchase prices were between $30.97 and $54.03, with an estimated average price of $39.18. The stock is now traded at around $32.930000. The impact to a portfolio due to this purchase was 0.43%. The holding were 44,000 shares as of 2021-12-31.

Sector Gamma As added to a holding in Incyte Corp by 25.14%. The purchase prices were between $63.34 and $74.11, with an estimated average price of $67.48. The stock is now traded at around $70.070000. The impact to a portfolio due to this purchase was 1.31%. The holding were 378,852 shares as of 2021-12-31.

Sector Gamma As added to a holding in Novavax Inc by 20.84%. The purchase prices were between $134.56 and $217.97, with an estimated average price of $172.19. The stock is now traded at around $83.450000. The impact to a portfolio due to this purchase was 0.08%. The holding were 13,346 shares as of 2021-12-31.

Sector Gamma As sold out a holding in Baxter International Inc. The sale prices were between $74.57 and $87.19, with an estimated average price of $80.52.

Sector Gamma As reduced to a holding in Merck & Co Inc by 41.46%. The sale prices were between $72.28 and $90.54, with an estimated average price of $79.6. The stock is now traded at around $76.910000. The impact to a portfolio due to this sale was -5.05%. Sector Gamma As still held 475,804 shares as of 2021-12-31.